The Role of Real World Evidence in Health Technology Assessment over Time: A Research on the French Situation

2021-01-13T16:59:03+00:00 December 17th, 2020|Featured, Publications|

  • Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2020

  • Authors: Radoszycki L, Wilczynski O, Avril D

Real-World Evidence (RWE) is more and more recognized as a valuable source of evidence and has been a growing focus of Health Technology Assessment (HTA) in the past few years. The HTA body in France is called the Haute Autorité de Santé (HAS) (National Authority for Health) and commissions the Transparency Committee to evaluate post-registration studies.